|
Vaccine Detail
Actinobacillus pleuropneumoniae apxIA mutant vaccine |
Vaccine Information |
- Vaccine Name: Actinobacillus pleuropneumoniae apxIA mutant vaccine
- Target Pathogen: Actinobacillus pleuropneumoniae
- Target Disease: porcine pleuropneumonia
- Vaccine Ontology ID: VO_0002766
- Type: Live, attenuated vaccine
- Status: Research
- apxIA
gene engineering:
- Type: Gene mutation
- Description: This apxIA mutant is from Actinobacillus pleuropneumoniae (Xu et al., 2006).
- Detailed Gene Information: Click Here.
- Immunization Route: intranasal immunization
|
Host Response |
Pig Response
- Persistence: An apxIA mutant is attenuated in pigs (Xu et al., 2006).
- Efficacy: An apxIA mutant offered a level of cross-serovar protection against A. pleuropneumoniae infection in pigs (Xu et al., 2006).
Mouse Response
- Persistence: An apxIA mutant is attenuated in mice (Xu et al., 2006).
- Efficacy: An apxIA mutant offered a level of cross-serovar protection against A. pleuropneumoniae infection in mice (Xu et al., 2006).
|
References |
Xu et al., 2006: Xu F, Chen X, Shi A, Yang B, Wang J, Li Y, Guo X, Blackall PJ, Yang H. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae. Veterinary microbiology. 2006; 118(3-4); 230-239. [PubMed: 16930871].
|
|